Namala Kalyan Chakravarthi

Namala Kalyan Chakravarthi

Active Director Director DIN 03167849
DIN 03167849 First appointment Sep 2010 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Sep 2010
Shareholding value •••• Premium profile

About Namala Kalyan Chakravarthi

Data last updated:

Namala Kalyan Chakravarthi is a Director at Kakinada Chit Funds Private Limited (since 2021), Director at Marainova Innovations Private Limited (since 2020) and Director at Coastal Laboratories Private Limited (since 2010). The companies operate in Financial Services, Aquaculture and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹31.4 Lakh; the largest is Kakinada Chit Funds Private Limited at ₹30 Lakh (FY 2017). Earlier, Namala Kalyan Chakravarthi was a Managing Director at Ingaran Biotech Private Limited (2011–2024).

DIN 03167849
Primary Designation Director
Industry Financial Services
First Appointment 07 Sep 2010
Oldest Company Age 30 yrs
Largest company Kakinada Chit Funds Private Limited · ₹30 Lakh (FY 2017)
Combined revenue ₹31.4 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kakinada Chit Funds Private Limited U65992AP1996PTC025202
Director30 Jun 20211996₹30 Lakh (FY 2017)Active
Director09 Jan 20202020₹1.4 Lakh (FY 2022)Active
Coastal Laboratories Private Limited U24100AP2010PTC070362
Director07 Sep 20102010Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ingaran Biotech Private Limited U01403TG2011PTC074400
Managing Director10 May 20112011Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Namala Kalyan Chakravarthi

Directorship timeline

Open interactive timeline →
Marainova Innovations Private Limited
Coastal Laboratories Private Limited
Kakinada Chit Funds Private Limited
Ingaran Biotech Private Limited
Premium access

Shareholding and investment profile for Namala Kalyan Chakravarthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Namala Kalyan Chakravarthi

Namala Kalyan Chakravarthi currently holds 3 directorships: Kakinada Chit Funds Private Limited (Director, since 30 Jun 2021, revenue ₹30 Lakh (FY 2017)); Marainova Innovations Private Limited (Director, since 09 Jan 2020, revenue ₹1.4 Lakh (FY 2022)); Coastal Laboratories Private Limited (Director, since 07 Sep 2010).

Namala Kalyan Chakravarthi was first appointed on 07 Sep 2010 as Director at Coastal Laboratories Private Limited. The most recent appointment on record is 30 Jun 2021 at Kakinada Chit Funds Private Limited.

The 2 current companies of Namala Kalyan Chakravarthi that report revenue have a combined latest revenue of ₹31.4 Lakh: Kakinada Chit Funds Private Limited ₹30 Lakh (FY 2017); Marainova Innovations Private Limited ₹1.4 Lakh (FY 2022).

Namala Kalyan Chakravarthi held 1 earlier board appointment: Ingaran Biotech Private Limited (Managing Director, 10 May 2011 to 29 Mar 2024).

The current boards of Namala Kalyan Chakravarthi's companies include Purushottam Muppana (Kakinada Chit Funds Private Limited), Ravitej Vemulapalli (Marainova Innovations Private Limited), Hara Sankar Behera (Coastal Laboratories Private Limited), Sunitha Namala (Coastal Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available